The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 7th 2025
The FDA approves dordaviprone, the first systemic therapy for H3 K27M-mutant diffuse midline glioma, offering hope for patients with limited options.
Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH
January 29th 2025The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.
Read More
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus
Published: January 23rd 2025 | Updated: January 23rd 2025Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Read More